Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Drugmakers Pfizer and BioNTech have said that their Covid-19 vaccine remained 100 per cent effective in children aged 12 to 15 years, four months after the second dose.
The companies said that the new data will help support their applications for full approval in the United States and worldwide.
The new study analysed 2,228 trial participants, the vaccine makers said.
According to an AFP report no serious safety concerns were observed in individuals with at least six months of follow-up after the second dose.
The vaccine was granted "emergency use authorization" for adolescents by the US in May and the companies plan to soon seek full approval. The vaccine is currently only fully approved in people aged 16 and older.
 

Pfizer Covid vaccine 100% effective in 12 to 15 year old children after 4 months

Good News: Pfizer Covid vaccine 100% effective in 12 to 15 year old children

Pfizer Covid vaccine 100% effective in 12 to 15 year old children

Pfizer Covid vaccine 100% effective in 12 to 15 year old children
Company says vaccine found to effective 4 months after&nbsp;2nd dose
Pfizer says new data will help get full approval&nbsp;for vaccine
Pfizer only vaccine fully approved for people aged 16 and above

Covid-19: Pfizer and BioNTech have said that their vaccine remained 100% effective in children aged 12 to 15 years, four months after the second dose

Drugmakers Pfizer and BioNTech have said that their Covid-19 vaccine remained 100 per cent effective in children aged 12 to 15 years, four months after the second dose.
The companies said that the new data will help support their applications for full approval in the United States and worldwide.
Also watch:&nbsp;<a href="https://www.editorji.com/world-news/israel-starts-covid-vaccines-for-kids-aged-5-to-11-amid-children-wave-fears-1637644971845" target="_blank">Israel starts Covid vaccines for kids aged 5 to 11 amid 'children wave' fears&nbsp;</a>
The new study analysed 2,228 trial participants, the vaccine makers said.
According to an AFP report, no serious safety concerns were observed in individuals with at least six months of follow-up after the second dose.
The vaccine was granted "emergency use authorization" for adolescents by the US in May and the companies plan to soon seek full approval. The vaccine is currently only fully approved in people aged 16 and older.
&nbsp;

New Zealand on Monday reported its first death linked to the Pfizer Cobid-19 vaccine, Reuters has reported.
The country's health ministry released details on the death of a woman following a review by an independent Covid-19 vaccine safety monitoring board.
The board concluded that the woman&rsquo;s death was due to myocarditis, which is known to be a rare side effect of the Pfizer Covid-19 vaccine, the govt said.
Myocarditis is an inflammation of the heart muscle that can limit its ability to pump blood and can cause changes in heartbeat rhythms.
"This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer Covid-19 vaccine," the health ministry said.
Reuters report said that Pfizer has not yet reacted to the death.
New Zealand is battling an outbreak of the Delta variant of Covid-19 after nearly six months of being virus free.
It reported 53 new cases on Monday, taking the total number of infections in the current outbreak to 562.

New Zealand records first death linked to Pfizer Covid-19 vaccine

New Zealand has reported its first death linked to Pfizer Cobid-19 vaccine

New Zealand has reported its first death linked to Pfizer Cobid-19 vaccine
Myocarditis&nbsp;is known to be a rare side effect of the Pfizer Covid-19 vaccine
Myocarditis: Inflammation of heart muscle can limit ability to pump blood&nbsp;
New Zealand&nbsp;battling Delta outbreak after 6 months of being virus free

New Zealand on Monday reported its first death linked to the Pfizer Cobid-19 vaccine, Reuters has reported

New Zealand on Monday reported its first death linked to the Pfizer Covid-19 vaccine, Reuters has reported.
The country's health ministry released details on the death of a woman following a review by an independent Covid-19 vaccine safety monitoring board.
The board concluded that the woman&rsquo;s death was due to myocarditis, which is known to be a rare side effect of the Pfizer Covid-19 vaccine, the govt said.
Myocarditis is an inflammation of the heart muscle that can limit its ability to pump blood and can cause changes in heartbeat rhythms.
"This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer Covid-19 vaccine," the health ministry said.
Reuters report said that Pfizer has not yet reacted to the death.
New Zealand is battling an outbreak of the Delta variant of Covid-19 after nearly six months of being virus free.
It reported 53 new cases on Monday, taking the total number of infections in the current outbreak to 562.

The US drug regulator gave full approval to Pfizer's Covid-19 vaccine on Monday for people 16 and older, making it the first to move beyond emergency use status.
This has made the two-shot Pfizer vaccine the first to receive full approval from the federal government.
“After a thorough, independent, and rigorous scientific review process that began more than a year ago, the FDA gave full approval to the Pfizer vaccine. Today’s announcement reaffirms the FDA’s findings that the vaccine is safe and effective,” the White House said.
Public health experts hope that this move will convince more unvaccinated Americans that Pfizer's shot is safe and effective.
The Pfizer vaccine has been in use in the US under an emergency authorisation since December 2020. Since then, more than 200 million Pfizer doses have been administered in the US.

US drug regulator gives full approval to Pfizer Covid-19 vaccine

The US drug regulator gave full approval to Pfizer's Covid-19 vaccine on Monday for people 16 and older, making it the first to move beyond emergency use status.

The US drug regulator gave full approval to Pfizer's Covid-19 vaccine on Monday for people 16 and older, making it the first to move beyond emergency use status.
This has made the two-shot Pfizer vaccine the first to receive full approval from the federal government.
&ldquo;After a thorough, independent, and rigorous scientific review process that began more than a year ago, the FDA gave full approval to the Pfizer vaccine. Today&rsquo;s announcement reaffirms the FDA&rsquo;s findings that the vaccine is safe and effective,&rdquo; the White House said.
Public health experts hope that this move will convince more unvaccinated Americans that Pfizer's shot is safe and effective.
The Pfizer vaccine has been in use in the US under an emergency authorisation since December 2020. Since then, more than 200 million Pfizer doses have been administered in the US.

The US drug regulator gave full approval to Pfizer's Covid-19 vaccine on Monday for people 16 and older, making it the first to move beyond emergency use status.
&nbsp;

The US drug regulator gave full approval to<a href="https://www.editorji.com/coronavirus/pfizer-vaccine-for-omicron-to-be-ready-in-march-for-approval-ceo-1641878458638" target="_blank"> Pfizer's Covid-19 vaccine</a> on Monday for people 16 and older, making it the first to move beyond emergency use status.
This has made the two-shot Pfizer vaccine the first to receive full approval from the federal government.
Also See |&nbsp;<a href="https://www.editorji.com/story/meet-zycov-d-the-world-s-first-dna-covid-19-vaccine-everything-you-need-to-know-about-the-new-vaccine-1629658709134" target="_blank">ZyCoV-D:&nbsp;The world&rsquo;s first DNA&nbsp;Covid-19&nbsp;vaccine; everything you need to know about the new vaccine</a>
&ldquo;After a thorough, independent, and rigorous scientific review process that began more than a year ago, the FDA gave full approval to the Pfizer vaccine. Today&rsquo;s announcement reaffirms the FDA&rsquo;s findings that the vaccine is safe and effective,&rdquo; the White House said.
Public health experts hope that this move will convince more unvaccinated Americans that Pfizer's shot is safe and effective.
The Pfizer vaccine has been in use in the US under an emergency authorisation since December 2020. Since then, more than 200 million Pfizer doses have been administered in the US.

Total antibody levels start to drop six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, according to study published in The Lancet journal. The study adds the levels can reduce by more than 50 per cent over 10 weeks.
The findings based on data from over 600 people aged 18 and above were consistent across all groups of people regardless of age, chronic illnesses or sex.
The researchers from University College London (UCL) warned protective effects of the vaccines may also begin to wear off, particularly against new variants if the antibody levels carry on dropping at this rate.
The UCL Virus Watch study also found that antibody levels are substantially higher following two doses of the Pfizer vaccine than after two shots of the AstraZeneca preventive, known as Covishield in India.
Further, the study showed that antibody levels were much higher in vaccinated people than those with prior SARS-CoV-2 infection.
The findings support recommendations that adults who are clinically vulnerable, or those aged 70 years or over should be prioritised for booster doses

Pfizer, AstraZeneca vaccine antibody levels may decline after 2-3 months: Lancet study

Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to Lancet study

Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to Lancet study

Total antibody levels start to drop six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, according to study published in The Lancet journal. The study adds the levels can reduce by more than 50 per cent over 10 weeks.
The findings based on data from over 600 people aged 18 and above were consistent across all groups of people regardless of age, chronic illnesses or sex.
The researchers from University College London (UCL) warned protective effects of the vaccines may also begin to wear off, particularly against new variants if the antibody levels carry on dropping at this rate.
The UCL Virus Watch study also found that antibody levels are substantially higher following two doses of the Pfizer vaccine than after two shots of the AstraZeneca preventive, known as Covishield in India.
Further, the study showed that antibody levels were much higher in vaccinated people than those with prior SARS-CoV-2 infection.
The findings support recommendations that adults who are clinically vulnerable, or those aged 70 years or over should be prioritised for booster doses

The Palestinian Authority has cancelled a deal under which Israel was to give it at least one million Covid vaccines. The authority said the Pfizer jabs were "about to expire." Israel earlier said, it didn't need an ageing stock of vaccines and they could be used to speed up the Palestinian vaccination programme.In return, the Palestinians were to give Israel a similar number of vaccines they are expecting from Pfizer later in the year. However, when the first batch of jabs from Israel arrived, Palestinian officials said they were even nearer their expiry date than expected.About 55% of eligible Israelis have been given both doses as part of a mass vaccination campaign. Some 30% of eligible Palestinians in the occupied West Bank and Gaza have received at least one vaccine dose, according to Palestinian officials.

Palestine cancels Covid vaccine sharing deal with Israel, says Pfizer jabs 'about to expire'

Palestine cancels Covid vaccine sharing deal with Israel, says Pfizer jabs that Israel sent were 'about to expire'

Palestinian Authority cancels vaccine sharing deal with Israel
Israel was to give Palestine at least one million Covid vaccines
Palestinian authority said the Pfizer jabs were 'about to expire'
In return, Palestinians were to give Israel a similar number of jabs
About 55% of eligible Israelis have been given both vaccine doses
Some 30% of eligible Palestinians received at least 1 vaccine dose

The Palestinian Authority has cancelled a deal under which Israel was to give it at least one million Covid vaccines. The authority said the Pfizer jabs were "about to expire." Israel earlier said, it didn't need an ageing stock of vaccines and they could be used to speed up the Palestinian vaccination programme. In return, the Palestinians were to give Israel a similar number of vaccines they are expecting from Pfizer later in the year. However, when the first batch of jabs from Israel arrived, Palestinian officials said they were even nearer their expiry date than expected. About 55% of eligible Israelis have been given both doses as part of a mass vaccination campaign. Some 30% of eligible Palestinians in the occupied West Bank and Gaza have received at least one vaccine dose, according to Palestinian officials.

Covid-19 vaccine Covishield maker Serum Institute of India (SII) has demanded indemnity from liability, reports said quoting sources, adding not just SII but &lsquo;all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it&rsquo;.&nbsp;
This comes amid reports that India might grant indemnity to foreign drug companies such as Pfizer and Moderna. &nbsp;
Indemnity from liability is a key condition put forth by vaccine-makers Pfizer and Moderna for supplying their Covid shots to India. Pfizer has immunity in countries like the US where it cannot be sued for any adverse effects.&nbsp;
The government has not given any manufacturer indemnity or protection against legal action for any severe side effects so far.&nbsp;
What is indemnity and why are Covid vaccine makers seeking it?&nbsp;
With all the buzz around indemnity demand, one might wonder about the relevance of the term and why vaccine makers are pressing for it.&nbsp;
Indemnity is a sort of protection that pharma companies seek to shield themselves from potential compensation demands from those who may experience adverse effects after getting vaccinated.&nbsp;
Indemnity is like granting a concessional request of legal defence from any claims associated with the use of companies' COVID vaccines in India&nbsp;
When a pharma company has indemnity granted by the government of the country it is operating, it means it cannot be sued for negligence related to administering the vaccine. &nbsp;
The company will not be liable to answer if someone suffers side effects and decides to take the matter to court. The government will instead have to become the respondent there.&nbsp;
What is the status in other countries?&nbsp;
Both Pfizer and Moderna have received protection against lawsuits through indemnity clauses for their Covid-19 vaccines in other countries, including the US and Brazil. &nbsp;
The vaccines developed by Pfizer and Moderna work on the same technology and they have proved to be more than 90 per cent effective against Covid-19. Also, these vaccines have been approved in more than 40 countries.&nbsp;
Will they? Will they not?&nbsp;
The Health Ministry, citing other countries have reportedly said and "there is no problem" in granting indemnity or legal protection from any claims linked to the use of a company's COVID-19 vaccine.&nbsp;&nbsp;The Health Ministry sources further said that indemnity can be given if foreign pharma companies have applied for Emergency Use Authorisation in India.&nbsp;
Pfizer and Moderna have said they will export their COVID-19 vaccines to India only if the company is guarded against legal cases.&nbsp;
In February this year, Pfizer became the first foreign drugmaker to apply for emergency use approval of its vaccine candidate in India, but the application was later withdrawn. Later, in May Pfizer said it is holding fresh talks with the Indian government.&nbsp;&nbsp;Pfizer&rsquo;s spokesperson stressed that the safety and efficacy data of the vaccine had been backed by regulatory authorities in US, Britain, Japan and the World Health Organization.&nbsp;
In the wake of acute shortage of COVID-19 vaccine, the Centre has been strongly criticised for its vaccination policy. The government halted the exports of coronavirus vaccine shots earlier given under its "Vaccine Maitri" programme and scrambled to procure more jabs to address the shortage. In this scenario it looks likely that it will grant indemnity to Pfizer, Moderna, and SII to expedite the vaccination process in the country.&nbsp;
The government will look at the indemnity clause &lsquo;on the basis of practices followed internationally&rsquo;, sources said.&nbsp;

Indemnity: What is it? What do pharma majors like Pfizer, Moderna & SII want it?

Covid-19 vaccine Covishield maker Serum Institute of India (SII) has demanded indemnity from liability, reports said quoting sources, adding not just SII but &lsquo;all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it&rsquo;.&nbsp;
 This comes amid reports that India might grant indemnity to foreign drug companies such as Pfizer and Moderna. &nbsp;
Indemnity from liability is a key condition put forth by vaccine-makers Pfizer and Moderna for supplying their Covid shots to India. Pfizer has immunity in countries like the US where it cannot be sued for any adverse effects.&nbsp;
The government has not given any manufacturer indemnity or protection against legal action for any severe side effects so far.&nbsp;
What is indemnity and why are Covid vaccine makers seeking it?&nbsp;
With all the buzz around indemnity demand, one might wonder about the relevance of the term and why vaccine makers are pressing for it.&nbsp;
Indemnity is a sort of protection that pharma companies seek to shield themselves from potential compensation demands from those who may experience adverse effects after getting vaccinated.&nbsp;
Indemnity is like granting a concessional request of legal defence from any claims associated with the use of companies' COVID vaccines in India&nbsp;
When a pharma company has indemnity granted by the government of the country it is operating, it means it cannot be sued for negligence related to administering the vaccine. &nbsp;
The company will not be liable to answer if someone suffers side effects and decides to take the matter to court. The government will instead have to become the respondent there.&nbsp;
What is the status in other countries?&nbsp;
Both Pfizer and Moderna have received protection against lawsuits through indemnity clauses for their Covid-19 vaccines in other countries, including the US and Brazil. &nbsp;
The vaccines developed by Pfizer and Moderna work on the same technology and they have proved to be more than 90 per cent effective against Covid-19. Also, these vaccines have been approved in more than 40 countries.&nbsp;
Will they? Will they not?&nbsp;
The Health Ministry, citing other countries have reportedly said and "there is no problem" in granting indemnity or legal protection from any claims linked to the use of a company's COVID-19 vaccine.&nbsp;&nbsp;The Health Ministry sources further said that indemnity can be given if foreign pharma companies have applied for Emergency Use Authorisation in India.&nbsp;
Pfizer and Moderna have said they will export their COVID-19 vaccines to India only if the company is guarded against legal cases.&nbsp;
In February this year, Pfizer became the first foreign drugmaker to apply for emergency use approval of its vaccine candidate in India, but the application was later withdrawn. Later, in May Pfizer said it is holding fresh talks with the Indian government.&nbsp;&nbsp;Pfizer&rsquo;s spokesperson stressed that the safety and efficacy data of the vaccine had been backed by regulatory authorities in US, Britain, Japan and the World Health Organization.&nbsp;
In the wake of acute shortage of COVID-19 vaccine, the Centre has been strongly criticised for its vaccination policy. The government halted the exports of coronavirus vaccine shots earlier given under its "Vaccine Maitri" programme and scrambled to procure more jabs to address the shortage. In this scenario it looks likely that it will grant indemnity to Pfizer, Moderna, and SII to expedite the vaccination process in the country.&nbsp;
The government will look at the indemnity clause &lsquo;on the basis of practices followed internationally&rsquo;, sources said.&nbsp;

Covid-19 vaccine Covishield maker Serum Institute of India (SII) has demanded indemnity from liability, reports said quoting sources. The SII&nbsp;said &lsquo;all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it&rsquo;.&nbsp;
 This comes amid reports that India might grant indemnity to foreign drug companies such as Pfizer and Moderna. &nbsp;
Indemnity from liability is a key condition put forth by vaccine-makers Pfizer and Moderna for supplying their Covid shots to India. Pfizer has immunity in countries like the US where it cannot be sued for any adverse effects.&nbsp;
The government has not given any manufacturer indemnity or protection against legal action for any severe side effects so far.&nbsp;
What is indemnity and why are Covid vaccine makers seeking it?&nbsp;
With all the buzz around indemnity demand, one might wonder about the relevance of the term and why vaccine makers are pressing for it.&nbsp;
Indemnity is a legal clause mostly used by insurance companies and claims companies to seek to shield themselves from potential compensation demands from those who may experience adverse effects after getting vaccinated.&nbsp;
Indemnity is like granting a concessional request of legal defence from any claims associated with the use of companies' COVID vaccines in India&nbsp;
When a pharma company has indemnity granted by the government of the country it is operating, it means it cannot be sued for negligence related to administering the vaccine. &nbsp;
The company will not be liable to answer if someone suffers side effects and decides to take the matter to court. The government will instead have to become the respondent there.&nbsp;
What is the status in other countries?&nbsp;
Both Pfizer and Moderna have received protection against lawsuits through indemnity clauses for their Covid-19 vaccines in other countries, including the US and Brazil. &nbsp;
The vaccines developed by Pfizer and Moderna work on the same technology and they have proved to be more than 90 per cent effective against Covid-19. Also, these vaccines have been approved in more than 40 countries.&nbsp;
Will they? Will they not?&nbsp;
The Health Ministry, citing other countries have reportedly said and "there is no problem" in granting indemnity or legal protection from any claims linked to the use of a company's COVID-19 vaccine.&nbsp;&nbsp;The Health Ministry sources further said that indemnity can be given if foreign pharma companies have applied for Emergency Use Authorisation in India.&nbsp;
Pfizer and Moderna have said they will export their COVID-19 vaccines to India only if the company is guarded against legal cases.&nbsp;
In February this year, Pfizer became the first foreign drugmaker to apply for emergency use approval of its vaccine candidate in India, but the application was later withdrawn. Later, in May Pfizer said it is holding fresh talks with the Indian government.&nbsp;&nbsp;Pfizer&rsquo;s spokesperson stressed that the safety and efficacy data of the vaccine had been backed by regulatory authorities in US, Britain, Japan and the World Health Organization.&nbsp;
In the wake of acute shortage of COVID-19 vaccine, the Centre has been strongly criticised for its vaccination policy. The government halted the exports of coronavirus vaccine shots earlier given under its "Vaccine Maitri" programme and scrambled to procure more jabs to address the shortage. In this scenario it looks likely that it will grant indemnity to Pfizer, Moderna, and SII to expedite the vaccination process in the country.&nbsp;
The government will look at the indemnity clause &lsquo;on the basis of practices followed internationally&rsquo;, sources said.&nbsp;

The European Union&rsquo;s drug watchdog on Friday approved the Pfizer/BioNTech&nbsp;coronavirus&nbsp;jab for 12 to 15-year-olds, becoming the first vaccine to get the green light for children in the bloc.&nbsp;Amsterdam-based European Medicines Agency said, the vaccine was &ldquo;well tolerated" in children and there were no &ldquo;major concerns" in terms of side effects. Germany has said it will start vaccinating children over the age of 12 from June 7 following the authorisation by the EMA.&nbsp;The United States and Canada have both already authorised the vaccine for children of the same age.

European Union's drug regulator approves Pfizer vaccine for 12 to 15 year olds

EU drug regulator approves Pfizer vaccine for children
12 to 15 year olds&nbsp;can receive the vaccine in the Europe
Pfizer vaccine first to get the nod for children in EU
EMA: vaccine well tolerated, so side-effects were seen
Germany to start vaccinating children from June 7
US and Canada have authorised Pfizer's jab for kids
&nbsp;

The European Union&rsquo;s drug watchdog on Friday approved the Pfizer/BioNTech&nbsp;coronavirus&nbsp;jab for 12 to 15-year-olds, becoming the first vaccine to get the green light for children in the bloc.&nbsp;Amsterdam-based European Medicines Agency said, the vaccine was &ldquo;well tolerated" in children and there were no &ldquo;major concerns" in terms of side effects. Germany has said it will start vaccinating children over the age of 12 from June 7 following the authorisation by the EMA.&nbsp;The United States and Canada have both already authorised the vaccine for children of the same age.

On today's episode of Ask the Doctor, Dr. Anita Shet, Director of Child Health at the International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, explains why Covid&nbsp;vaccines are safe for children and extensive trials are done before the Pfizer vaccine was approved by the US FDA. She adds, it is crucial to vaccinate children&nbsp;as that can help break the cycle of transmission of newer variants.
&nbsp;

Ask The Doctor | Covid vaccines are safe for children, assures Dr Anita Shet

<ul style="list-style-type: circle;">
<li>Vikram: To what extent do you think it's important for teenagers say 12-18 or 18-25, how important is it for them to actually get vaccinated? vaccines for children....how imp is it for children, teens to get vaccinated?</li>
</ul>
&nbsp;
<ul style="list-style-type: circle;">
<li>Anita Shet: So here is another good question. So the short answer to your question is that it is very important to get your children vaccinated. But that's as I said is just a quick answer. We need to think of all the factors and maybe even go into why the answer is that why is it important for these children to get vaccinated. The main reasons are that of course&nbsp;children need to be protected it is for their own safety and health. In general, we know that children have a milder case of infection compared to older adults, they are definitely less severe but however, the few of them who get the infection...they are severe cases that are reported, typically they are one in thousand or so who get very severe illnesses. In the second wave actually, we see a lot of that, children with underlying conditions like diabetes or asthma then tend to have a really bad infection when they get Covid. The second reason is to stop transmission. In India, the proportion of children under 18 years of age is 41%, so imagine almost half of the entire population is children. So if you want to stop the viral transmission in the country we can't leave out children they have to be considered to a large extent. We need that herd immunity to reach at least&nbsp;what we think is 70-80%, so children have to be included. And the third important reason is that we have to stop viral variants, we have to stop mutations occurring and for that, we need to remove this host population that is carrying this virus, transmitting it, even though they don't fall ill. Recently, we had studied from Israel showing that giving vaccines can keep the variants in check. So, for all these reasons it is important to vaccinate children. Having said that, we have to consider two very important things. One of them is safety which is children are slightly different from adults, their immune systems are different, dosages might be different, so they have to be studied carefully. There can't be any shortcuts, so we need those trials to go on. And the second thing to consider is what you spoke about just now, which is we have to absolutely consider vaccine availability and vaccine access. So right now it is going slow in India for multiple reasons and we really need the high priority populations to be vaccinated. that includes the older adults, people in the frontline and so on. Unless we get those aspects sorted out, we have a good vaccine supply we will not be able to go into children. But that's the entire picture for how to get children vaccinated.</li>
</ul>
&nbsp;
<ul style="list-style-type: circle;">
<li>Vikram: Can vaccines actually stop Covid? Bur specifically on children once again because this is exactly what you are studying, so are the vaccines safe for children? Not all of them are authorised for children, so far. Not all of them have been tested on children, so far. So that makes some parents and another worry is safe, should we be giving vaccines to our children. Or is it just because that's the feasing in which trials have happened and it's just not been tested yet. Is there any reason to believe that the vaccines won't be safe for the children?</li>
</ul>
&nbsp;
<ul style="list-style-type: circle;">
<li>Anita Shet: Right, so that is also a question that has been looked into quite a bit. So far there is no evidence that suggests vaccines may be less safe compared to adults and we have data coming out from the existing trials like the MRNA trials, the ones that are most advanced in trials in children. So, the Pfizer vaccine has been tested in children 12 years and above and the data arrived and it received emergency authorisation and it is being rolled out in the United States. In the UK, the AstraZeneca vaccine is also being tested in children between 6-17 years of age. They started the trial in Feb this year and it has been halted and now they are re-starting the trial. So we should have data from the AstraZeneca vaccine. And the third vaccine is the BharatBiotech vaccine which is the inactivated vaccine, this type of technology has been used for many of the other vaccines that we have in existence. So again, for that technology, we have no reason to believe that it will not be safe for children. So that vaccine, Covaxin is going to start trials in a month or so in India. There is paperwork submitted and they have received some of the approvals from the Indian government to start trials in children to 18 years of age. So we should have some data coming in regarding the safety as well as the indigenousity of the vaccines. </li>
</ul>

On today's episode of Ask the Doctor, Dr. Anita Shet, Director of Child Health at the International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, explains why Covid&nbsp;vaccines are safe for children and extensive trials are done before the Pfizer vaccine was approved by the US FDA. She adds, it is crucial to vaccinate children&nbsp;as that can help break the cycle of transmission of newer variants.
&nbsp;

pfizer vaccine

Categories